Login to Your Account


Flood of cash washes over biopharma companies during the first quarter

By Peter Winter

Monday, April 7, 2014

Notwithstanding market nervousness toward the end the first quarter of 2014 the period was characterized by a tsunami of cash flooding into biotech coffers. Both global public and private companies benefited. As a result, the sector collectively raised $9.5 billion – almost double the amount raised in the same period last year according to data from BioWorld Snapshots.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription